
The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease
30.05.2025
0:00
46:25
Targeting the cardiovascular (CV)-kidney-metabolic (CKM) axis may improve outcomes in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) by addressing interconnected metabolic, kidney, and CV risks. Credit available for this activity expires: 5/30/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002559?ecd=bdc_podcast_libsyn_mscpedu
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002559?ecd=bdc_podcast_libsyn_mscpedu
Więcej odcinków z kanału "Keeping Current CME"
Nie przegap odcinka z kanału “Keeping Current CME”! Subskrybuj bezpłatnie w aplikacji GetPodcast.